title: Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities.
authors: C
authors: C
authors: Vicente
authors: I
authors: I
authors: Vazquez
authors: A
authors: A
authors: Conchillo
authors: M A
authors: MA
authors: García-Sánchez
authors: N
authors: N
authors: Marcotegui
authors: O
authors: O
authors: Fuster
authors: M
authors: M
authors: González
authors: M J
authors: MJ
authors: Calasanz
authors: I
authors: I
authors: Lahortiga
authors: M D
authors: MD
authors: Odero
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000235:genetics; D002869:Chromosome Aberrations; D005260:Female; D050989:GATA2 Transcription Factor / Q000235:genetics*; D015870:Gene Expression; D006801:Humans; D007621:Karyotyping; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000235:genetics* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D055815:Young Adult
chemical_list: D014408:Biomarkers, Tumor; D050989:GATA2 Transcription Factor; C494711:GATA2 protein, human